Walgreens Cool N Heat

Description

This product is a topical pain relief stick formulated for extra strength therapy, designed to provide a cooling and heating sensation. It is comparable to the active ingredients found in Icy Hot® Chill Stick. The product is manufactured by Walgreens and is presented in a stick dosage form. Each stick contains a net weight of 2 ounces (56.7 grams) and is identified by the National Drug Code (NDC) 10889-201-11.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including arthritis, simple backache, bursitis, tendonitis, muscle strains, muscle sprains, bruises, and cramps.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 10 years or older, the recommended dosage involves applying the product generously to the affected area. The area should be massaged until the product is thoroughly absorbed into the skin. This application may be repeated as necessary, but should not exceed four times daily.

For children under 10 years of age, it is advised to consult a healthcare professional before use.

Contraindications

The product should not be used in the following situations:

Tight bandaging or the use of heating pads in conjunction with this product is contraindicated, as it may lead to adverse effects. Additionally, contact with the eyes and mucous membranes must be avoided to prevent irritation or injury. The application of this product on wounds or damaged skin is also contraindicated due to the potential for exacerbating the condition or causing further harm.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients who are pregnant or breastfeeding to consult with a health professional prior to use to ensure safety for both the mother and child.

An allergy alert is warranted; patients should be cautioned against using this product if they have a known allergy to salicylates, including aspirin, without prior consultation with a physician.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients are advised to discontinue use and consult a healthcare provider if any of the following occur: the condition worsens, symptoms persist for more than 7 days, symptoms resolve and then recur within a few days, redness appears, or irritation develops. Monitoring for these signs is essential to ensure patient safety and effective management of their condition.

Side Effects

Patients should be aware that the product is intended for external use only. It is advised that individuals who are pregnant or breastfeeding consult a healthcare professional prior to use. An allergy alert is also in place; patients should not use this product if they are allergic to salicylates, including aspirin, without first consulting a physician.

In the event of adverse reactions, patients are instructed to stop use and seek medical advice if any of the following occur: the condition worsens, symptoms persist for more than 7 days, symptoms clear up and then recur within a few days, redness is present, or irritation develops. These precautions are essential to ensure the safety and well-being of patients using the product.

Drug Interactions

Patients with a known allergy to salicylates, including aspirin, should avoid the use of this medication unless they have consulted with a physician. This precaution is essential to prevent potential allergic reactions.

No specific drug or laboratory test interactions have been identified in the available data. Therefore, routine monitoring or dosage adjustments related to drug interactions are not necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Walgreens Cool N Heat (methyl salicylate and menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 10 years of age should consult a healthcare professional before use. It is important to assess the appropriateness of treatment and dosage for this age group, as specific recommendations may vary based on individual health needs and conditions.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Additionally, specific antidotes or treatments may be indicated based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist is recommended for guidance on the appropriate management strategies.

Overall, vigilance and prompt intervention are critical in managing cases of suspected overdose to mitigate potential complications and ensure patient safety.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to stop using the product and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, if symptoms clear up and then recur within a few days, if redness is present, or if irritation develops.

When using this product, patients must be reminded to use it only as directed. They should not bandage the area tightly or use it in conjunction with a heating pad. It is also important to advise patients to avoid contact with their eyes and mucous membranes, and to refrain from applying the product to wounds or damaged skin.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature, away from excessive heat to maintain its integrity. It is essential to keep the product out of reach of children to ensure safety. Once opened, the product must be discarded to prevent any potential degradation or contamination.

Additional Clinical Information

The product is administered topically, with specific instructions for different age groups. Adults and children aged 10 years and older should apply the product generously to the affected area, massaging until fully absorbed, and may repeat this process up to four times daily. For children under 10 years of age, consultation with a doctor is advised prior to use.

Clinicians should counsel patients on important safety information. The product is for external use only, and individuals who are pregnant or breastfeeding should seek advice from a healthcare professional before use. Patients should be alerted to the risk of allergic reactions, particularly if they are allergic to salicylates, including aspirin. While using the product, patients should follow directions carefully, avoiding tight bandaging or the use of heating pads, and should prevent contact with eyes and mucous membranes. It is contraindicated for application on wounds or damaged skin. Patients are advised to discontinue use and consult a doctor if their condition worsens, symptoms persist beyond seven days, or if irritation or redness develops. Additionally, the product should be kept out of reach of children, and immediate medical attention should be sought if ingested.

Drug Information (PDF)

This file contains official product information for Walgreens Cool N Heat, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)